Blog - Page 2 of 5607 - QualityStocks

WednesdayApr 15, 2026 10:09 am

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Appoints Samuel Reid as Government Strategy and Procurement Advisor

American Fusion (OTC: AMFN), a developer of next-generation fusion energy technologies, announced it has entered into an advisory agreement with Samuel Reid, who will serve as Government Strategy and Procurement Advisor to support efforts to secure non-dilutive government funding, institutional contracts and alignment with U.S. and international fusion initiatives. Reid brings experience in government contracting, defense procurement and international agency engagement, including work with NATO-affiliated procurement bodies and the Canadian Department of National Defence, and currently serves as founder and CEO of Geometric Energy Corporation, as the company positions government and defense channels as a near-term pathway for funding, early-stage revenue and…

WednesdayApr 15, 2026 9:59 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Engages Venture Liquidity Providers for Market-Making Services

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), a biotechnology company focused on AI-driven voice analytics for drug and alcohol intoxication detection, announced it has appointed Venture Liquidity Providers (VLP), subject to regulatory and final approvals, to provide market-making services aimed at maintaining an orderly trading market for its common shares. The service will be conducted through W.D. Latimer Co. Ltd. in compliance with Canadian Securities Exchange policies, with MindBio agreeing to pay $5,000 per month over a 12-month term, which may be terminated at any time, while both parties operate at arm’s length and…

WednesdayApr 15, 2026 9:45 am

Compact Proton Therapy Delivery Helps Make the Treatment More Accessible for Cancer Patients

For a long time, proton therapy wasn’t available for many cancer patients due to the footprint of traditional proton therapy equipment and the high costs associated with it. However, the size and cost of this equipment is shrinking, opening it up as a more viable treatment option for cancer patients. Liora Technologies, a subsidiary of LIXTE Biotechnology Holdings, Inc., is poised to offer compact, precise, and accessible proton therapy through the innovative Linac for Image Guided Hadron Therapy (“LiGHT”) System. Proton therapy is a specialized cancer treatment that uses precision-guided radiation beams to target and destroy tumors while limiting harm…

WednesdayApr 15, 2026 9:45 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms NRx Defense Systems Subsidiary to Advance Neuroplastic Therapies for Military and Government Applications

NRx Pharmaceuticals (NASDAQ: NRXP), a biopharmaceutical company focused on neuroplastic therapies for depression and PTSD, announced the formation of NRx Defense Systems Inc., a Florida-based research and development subsidiary dedicated to advancing combined neuroplastic treatments using D-cycloserine and transcranial magnetic stimulation supported by robotic-enabled neuronavigation. The subsidiary will be led by Dr. Dennis McBride, with support from Chief Medical Innovation Officer Dr. Joshua Brown, and aims to pursue non-dilutive government and institutional funding while developing deployable solutions for military and first responder use, including a prototype in partnership with Zeta Surgical Inc. expected to be unveiled at the Clinical TMS…

WednesdayApr 15, 2026 9:35 am

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Issues 353,035 Shares for Research and Marketing Services Agreements

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF), a British Columbia-based phosphate exploration company, announced it has entered into agreements for equity research and marketing-related services, including research coverage and introductions to equity analysts, as well as graphic design, branding and website development. In connection with these agreements, the company has agreed to issue an aggregate of 353,035 common shares at a deemed price of $0.14 per share, including up to $7,435 in fees that may be paid in shares, with all securities issued…

WednesdayApr 15, 2026 9:15 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Launches Proposed Public Offering to Support Commercialization and AI Initiatives

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, announced it is commencing an underwritten public offering of shares of its common stock or common stock equivalents, with all securities to be offered by the company and the final size and terms subject to market conditions. The company said it intends to use net proceeds from the offering to advance commercialization of its FDA-cleared 12-lead synthesized ECG system, further development of its extended-wear patch and heart attack detection initiatives, enhance its AI capabilities and support working capital and general corporate purposes, with Titan Partners, a division of…

WednesdayApr 15, 2026 9:05 am

QualityStocksNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Partners With Structured Real Estate Group to Integrate Embedded Mortgage Platform Into AI-Driven Real Estate Ecosystem

Beeline Holdings (NASDAQ: BLNE) announced a strategic partnership with Structured Real Estate Group to integrate its Embedded Mortgage and Title solutions into SRG’s AI-driven real estate platform, enabling homebuyers to access personalized financing, evaluate total ownership costs and initiate the mortgage process within a single digital environment. The collaboration will support the development of approximately 2,000 smart homes in the Dallas-Fort Worth area over the next 36 months, combining advanced home technology, energy-efficient systems and integrated infrastructure with Beeline’s AI-powered assistant “Bob” to streamline the homebuying journey, reduce friction and deliver a more transparent, efficient path to homeownership while advancing…

WednesdayApr 15, 2026 9:00 am

Soligenix Inc. (NASDAQ: SNGX) Gains Analytical Validation as Pipeline Progress Drives Forward Outlook

A recent Zacks Small-Cap Research report outlines a number of key milestones that position Soligenix for a potentially eventful period ahead. One of the most notable elements highlighted in the analysis is the strength of the interim data trends observed thus far in the FLASH2 study. Beyond the phase 3 program, the report highlights additional clinical and scientific developments that contribute to the depth of Soligenix’s pipeline. Independent research coverage can play a meaningful role in shaping how emerging biotechnology companies are evaluated, particularly when it brings together clinical progress, financial positioning and forward-looking milestones into a cohesive outlook. A…

TuesdayApr 14, 2026 2:01 pm

QualityStocksNewsBreaks – Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Uncovers High-Value Rare Earth Trends in British Columbia

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF) recently reported promising early exploration results from its Cameron Rare Earth Element Project in British Columbia. An article discussing this reads, “Recent soil and rock sampling programs at the project have identified multiple areas of anomalous rare earth element mineralization associated with pegmatite systems… The Cameron project is located roughly 40 kilometers south of Revelstoke in British Columbia, along Highway 23 near the Columbia River. The property spans approximately 2,984 hectares within the Kamloops Mining Division. Powermax recently conducted a soil geochemical survey…

TuesdayApr 14, 2026 1:25 pm

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Showcased for Smarter Path to Drug Development

Soligenix (NASDAQ: SNGX) was featured in a recent article that discussed its positioning in a landscape where modern biopharmaceutical innovation often revolves around a powerful idea: One scientific mechanism can unlock treatments for multiple diseases. “Soligenix exemplifies this strategy through its use of synthetic hypericin across two distinct dermatologic indications, illustrating how platform science can streamline development and expand clinical impact,” the publication reads. “Platform-based drug development has gained traction across the biotechnology industry because of its efficiency and risk management advantages. In drug development, platform technology is a foundational technology or system that serves as a base for the development…

Site Search

Company Search